Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies

PRIMA Trial Investigators PATH, Ingemar S. J. Merkies, Ivo N. van Schaik, Jean-Marc Leger, Mika Saarela, Orell Mielke

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalJournal of the Peripheral Nervous System
Volume24
Issue number1
Pages (from-to)48-55
Number of pages8
ISSN1085-9489
DOIs
Publication statusPublished - Mar 2019
MoE publication typeA1 Journal article-refereed

Fields of Science

  • CIDP
  • efficacy
  • IVIG
  • PATH
  • PRIMA
  • INFLAMMATORY DEMYELINATING POLYNEUROPATHY
  • INTRAVENOUS IMMUNOGLOBULIN
  • MAINTENANCE TREATMENT
  • OPEN-LABEL
  • PHASE-III
  • POLYRADICULONEUROPATHY
  • PREVALENCE
  • 3112 Neurosciences
  • 3124 Neurology and psychiatry

Cite this

PRIMA Trial Investigators PATH, Merkies, I. S. J., van Schaik, I. N., Leger, J-M., Saarela, M., & Mielke, O. (2019). Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies. Journal of the Peripheral Nervous System, 24(1), 48-55. https://doi.org/10.1111/jns.12302
PRIMA Trial Investigators PATH ; Merkies, Ingemar S. J. ; van Schaik, Ivo N. ; Leger, Jean-Marc ; Saarela, Mika ; Mielke, Orell. / Efficacy and safety of IVIG in CIDP : Combined data of the PRIMA and PATH studies. In: Journal of the Peripheral Nervous System. 2019 ; Vol. 24, No. 1. pp. 48-55.
@article{7185b12124924e1eb405e69f5972e27d,
title = "Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies",
keywords = "CIDP, efficacy, IVIG, PATH, PRIMA, INFLAMMATORY DEMYELINATING POLYNEUROPATHY, INTRAVENOUS IMMUNOGLOBULIN, MAINTENANCE TREATMENT, OPEN-LABEL, PHASE-III, POLYRADICULONEUROPATHY, PREVALENCE, 3112 Neurosciences, 3124 Neurology and psychiatry",
author = "{PRIMA Trial Investigators PATH} and Merkies, {Ingemar S. J.} and {van Schaik}, {Ivo N.} and Jean-Marc Leger and Vera Bril and {van Geloven}, Nan and Hans-Peter Hartung and Lewis, {Richard A.} and Gen Sobue and John-Philip Lawo and Durn, {Billie L.} and Cornblath, {David R.} and {De Bleecker}, {Jan L.} and Claudia Sommer and Wim Robberecht and Mika Saarela and Jerzy Kamienowski and Zbigniew Stelmasiak and Bj{\"o}rn Tackenberg and Orell Mielke and A. Sabet and K. George and L. Roberts and R. Carne and S. Blum and R. Henderson and {Van Damme}, P. and J. Demeestere and S. Larue and C. D'Amour and P. Kunc and M. Valis and J. Sussova and T. Kalous and R. Talab and M. Bednar and T. Toomsoo and I. Rubanovits and K. Gross-Paju and U. Sorro and M. Auranen and J. Pouget and S. Attarian and {Le Masson}, G. and A. Wielanek-Bachelet and C. Desnuelle and E. Delmont and J. Schmidt",
year = "2019",
month = "3",
doi = "10.1111/jns.12302",
language = "English",
volume = "24",
pages = "48--55",
journal = "Journal of the Peripheral Nervous System",
issn = "1085-9489",
publisher = "Wiley",
number = "1",

}

PRIMA Trial Investigators PATH, Merkies, ISJ, van Schaik, IN, Leger, J-M, Saarela, M & Mielke, O 2019, 'Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies', Journal of the Peripheral Nervous System, vol. 24, no. 1, pp. 48-55. https://doi.org/10.1111/jns.12302

Efficacy and safety of IVIG in CIDP : Combined data of the PRIMA and PATH studies. / PRIMA Trial Investigators PATH; Merkies, Ingemar S. J.; van Schaik, Ivo N.; Leger, Jean-Marc; Saarela, Mika; Mielke, Orell.

In: Journal of the Peripheral Nervous System, Vol. 24, No. 1, 03.2019, p. 48-55.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Efficacy and safety of IVIG in CIDP

T2 - Combined data of the PRIMA and PATH studies

AU - PRIMA Trial Investigators PATH

AU - Merkies, Ingemar S. J.

AU - van Schaik, Ivo N.

AU - Leger, Jean-Marc

AU - Bril, Vera

AU - van Geloven, Nan

AU - Hartung, Hans-Peter

AU - Lewis, Richard A.

AU - Sobue, Gen

AU - Lawo, John-Philip

AU - Durn, Billie L.

AU - Cornblath, David R.

AU - De Bleecker, Jan L.

AU - Sommer, Claudia

AU - Robberecht, Wim

AU - Saarela, Mika

AU - Kamienowski, Jerzy

AU - Stelmasiak, Zbigniew

AU - Tackenberg, Björn

AU - Mielke, Orell

AU - Sabet, A.

AU - George, K.

AU - Roberts, L.

AU - Carne, R.

AU - Blum, S.

AU - Henderson, R.

AU - Van Damme, P.

AU - Demeestere, J.

AU - Larue, S.

AU - D'Amour, C.

AU - Kunc, P.

AU - Valis, M.

AU - Sussova, J.

AU - Kalous, T.

AU - Talab, R.

AU - Bednar, M.

AU - Toomsoo, T.

AU - Rubanovits, I.

AU - Gross-Paju, K.

AU - Sorro, U.

AU - Auranen, M.

AU - Pouget, J.

AU - Attarian, S.

AU - Le Masson, G.

AU - Wielanek-Bachelet, A.

AU - Desnuelle, C.

AU - Delmont, E.

AU - Schmidt, J.

PY - 2019/3

Y1 - 2019/3

KW - CIDP

KW - efficacy

KW - IVIG

KW - PATH

KW - PRIMA

KW - INFLAMMATORY DEMYELINATING POLYNEUROPATHY

KW - INTRAVENOUS IMMUNOGLOBULIN

KW - MAINTENANCE TREATMENT

KW - OPEN-LABEL

KW - PHASE-III

KW - POLYRADICULONEUROPATHY

KW - PREVALENCE

KW - 3112 Neurosciences

KW - 3124 Neurology and psychiatry

U2 - 10.1111/jns.12302

DO - 10.1111/jns.12302

M3 - Article

VL - 24

SP - 48

EP - 55

JO - Journal of the Peripheral Nervous System

JF - Journal of the Peripheral Nervous System

SN - 1085-9489

IS - 1

ER -